- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CHINA ISOTOPE & RADIATION Aktie jetzt für 0€ handeln | |||||
| Mi | CIRC (01763): VOLUNTARY ANNOUNCEMENT - RADIOACTIVE SOURCE R&D AND PRODUCTION BASE (PHASE II) SUCCESSFULLY GRANTED RADIATION SAFETY PERMIT, MARKING THE ... | 2 | HKEx | ||
| 29.05. | CIRC (01763): PROXY FORM FOR THE ANNUAL GENERAL MEETING | 2 | HKEx | ||
| 29.05. | CIRC (01763): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 29.05. | CIRC (01763): PROPOSED APPOINTMENT OF DIRECTOR PROPOSED ADOPTION OF CHINA ACCOUNTING STANDARDS FOR BUSINESS FOR THE PREPARATION OF FINANCIAL ACCOUNTING ... | - | HKEx | ||
| 27.05. | CIRC (01763): (1)PROPOSED ADOPTION OF CHINA ACCOUNTING STANDARDS FOR BUSINESS ENTERPRISES FOR THE PREPARATION OF FINANCIAL ACCOUNTING REPORTS; (2)PROPOSED ... | 1 | HKEx | ||
| 26.05. | CIRC (01763): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 2 | HKEx | ||
| 26.05. | CIRC (01763): RESIGNATION OF DIRECTOR AND PROPOSED APPOINTMENT OF DIRECTOR | 1 | HKEx | ||
| 08.05. | CIRC (01763): VOLUNTARY ANNOUNCEMENT - CONTRACT ON SECONDARY STANDARDIZED NEUTRON DOSIMETRY LABORATORY PROJECT TECHNICAL SERVICE ENTERED INTO BY CNGT, ... | 2 | HKEx | ||
| 22.04. | CIRC (01763): 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | 3 | HKEx | ||
| 22.04. | CIRC (01763): 2025 ANNUAL REPORT | 1 | HKEx | ||
| 28.03. | China Isotope & Radiation Corporation Reveals Decline In Full Year Income | - | RTTNews | ||
| 27.03. | CIRC (01763): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025 | 1 | HKEx | ||
| 27.03. | CIRC (01763): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 | - | HKEx | ||
| 19.03. | CIRC (01763): VOLUNTARY ANNOUNCEMENT - ENTERING INTO EQUITY TRANSFER AGREEMENT TO FURTHER EXPAND THE NON-DESTRUCTIVE TESTING BUSINESS LAYOUT | - | HKEx | ||
| 17.03. | CIRC (01763): DATE OF BOARD MEETING | - | HKEx | ||
| 13.03. | CIRC (01763): VOLUNTARY ANNOUNCEMENT - CIRC AND ITS SUBSIDIARY ZHONGHE HEADWAY ENTERED INTO STRATEGIC COOPERATION AGREEMENT WITH THE PEOPLE'S GOVERNMENT ... | 1 | HKEx | ||
| 02.03. | CIRC (01763): VOLUNTARY ANNOUNCEMENT - SELF-DEVELOPED 'RED BLOOD CELL LIFESPAN MEASUREMENT BREATH ANALYZER' OBTAINED CLASS II MEDICAL DEVICE REGISTRATION ... | 1 | HKEx | ||
| 12.02. | CIRC (01763): ANNOUNCEMENT - PROFIT WARNING | - | HKEx | ||
| 09.01. | CIRC (01763): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING | 3 | HKEx | ||
| 31.12.25 | CIRC (01763): INSIDE INFORMATION - TAX-RELATED ISSUE INVOLVING A SUBSIDIARY | 1 | HKEx |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,670 | +2,51 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 37,670 | +1,13 % | FRESENIUS SE & CO KGAA - Stabilität mit Fokus auf Struktur | ||
| SIEMENS HEALTHINEERS | 34,630 | +0,67 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 62,92 | +3,85 % | BrightSpring Health Services, Inc. (BTSG) is on the Move, Here's Why the Trend Could be Sustainable | ||
| CUPRINA HOLDINGS | 3,780 | +67,26 % | Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements | SINGAPORE, June 12, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,660 | -4,38 % | Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock? | ||
| GENEDX | 61,00 | +12,30 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| BILLIONTOONE | 100,71 | +1,46 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| HEARTFLOW | 32,980 | +12,06 % | Piper Sandler bestätigt Rating für Heartflow: Plaque-Umsätze sollen Wachstum antreiben | ||
| PROGYNY | 26,590 | +3,66 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| PROCEPT BIOROBOTICS | 25,500 | -12,34 % | PROCEPT BioRobotics shares slide after Leerink downgrade cites rising competitive risks | ||
| CARL ZEISS MEDITEC | 25,000 | +0,73 % | Carl Zeiss wächst deutlich weniger stark als im vergangenen Jahr und Carl Zeiss Meditec ist daran alles andere als unbeteiligt | Um neun Prozent konnte der Umsatz des Stiftungskonzerns Carl Zeiss im vergangenen Geschäftsjahr noch zulegen. Das Wachstum scheint sich jedoch deutlich abgeschwächt zu haben. Denn im ersten Halbjahr... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 8,425 | +7,19 % | Goldman Sachs initiates Lifestance Health stock at neutral | ||
| ALPHA TAU MEDICAL | 9,930 | +7,47 % | Alpha Tau Medical Ltd.: Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control | - Following the pre-specified interim safety report and overwhelming demand from clinicians to treat patients as quickly as possible, Alpha Tau to resume recruitment immediately for the remaining... ► Artikel lesen | |
| PACS GROUP | 36,530 | +6,44 % | Truist raises PACS Group stock price target to $52 on guidance |
CHINA ISOTOPE & RADIATION CORPORATION gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +1,08 % bei einem Aktienkurs von 1,870 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHINA ISOTOPE & RADIATION CORPORATION finden Sie auf Wallstreet Online.